Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amikacin Pharmacokinetics in Burn Patients
NCT02872272Phase 4Terminated
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Jan 2020
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amikacin in skin infection (SSTI), sponsored by Assistance Publique-Hôpitaux de Marseille. Started Jan 2020; status: terminated.
02
Drugs
amikacin
03
Conditions
skin infection (SSTI)
Beyond the preview
Go deeper on NCT02872272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02872272.